Pricing Log in Create free account
Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue
+38.3%
EPS
−294.7%
Free cash flow
+5.09%
Total debt
+40.8%

Quarter to June 2026, against a year earlier

24.11 2.55 −9.56%
Market cap
$5.6B
P/E
0.0×
Fwd P/E
−49.4×
Dividend yield
—
F-score
4/9
Altman Z
4.10
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 7, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 30, 2026 P1I2: 9 added · 5 removed · 45 modified
P2I1A: 32 added · 17 removed · 118 modified
8-K Aug 10, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 13, 2026 5.02 Departure or appointment of directors or officers
8-K Jun 26, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Jun 11, 2026 5.07 Submission of matters to a vote of security holders
8-K May 29, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 21, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 3.02 Unregistered sales of equity securities; 9.01 Financial statements and exhibits
8-K May 18, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 11, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 9, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 36 added · 9 removed · 56 modified
1A: 62 added · 12 removed · 150 modified
7: 22 added · 14 removed · 51 modified
8-K Feb 23, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 19, 2026 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 13, 2025 8.01 Other events
10-Q Sep 30, 2025
8-K Nov 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 28, 2025 5.02 Departure or appointment of directors or officers
8-K Sep 22, 2025 8.01 Other events
8-K Sep 1, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 4, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 24, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 4, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 26, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 6, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.